Android app Apple app link

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)'s Suzetrigine: 'I Don't See A Lot Of Upside Because That Was The Drug Of The Future For Vertex'

By Yahoo! Finance   |   1 month ago
Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)'s Suzetrigine: 'I Don't See A Lot Of Upside Because That Was The Drug Of The Future For Vertex'

Jim Cramer analyzed 9 stocks, including Vertex Pharmaceuticals, amidst economic uncertainty. He raised questions about Trump's policies, deregulation benefits, tax changes, and bond market tolerance for deficits. Cramer highlighted the unpredictable nature of Trump's presidency and suggested maintaining a higher cash position.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.